Last updated on April 2019

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease


Brief description of study

This is a Phase 3, open-label, multicenter extension study to evaluate safety and efficacy of ozanimod in subjects with moderately to severely active Crohn's Disease.

Clinical Study Identifier: NCT03467958

Contact Investigators or Research Sites near you

Start Over

CRU Hungary Kft

Miskolc, Hungary
0.82miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.